{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:14:46Z","timestamp":1783440886361,"version":"3.54.6"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"DOI":"10.7759\/cureus.82541","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T23:01:51Z","timestamp":1745017311000},"source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of Rheumatoid Factor and Anti-citrullinated Protein Antibodies in Patients With Post-treatment Lyme Disease"],"prefix":"10.7759","author":[{"given":"John B","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Rebman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Aucott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3201\/eid2702.202731","article-title":"Estimating the frequency of lyme disease diagnoses, United States, 2010-2018","volume":"27","author":"Kugeler KJ","year":"2021","unstructured":"Kugeler KJ, Schwartz AM, Delorey MJ, Mead PS, Hinckley AF. Estimating the frequency of lyme disease diagnoses, United States, 2010-2018. Emerg Infect Dis. 2021, 27:616-9. 10.3201\/eid2702.202731","journal-title":"Emerg Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.01.033","article-title":"Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: a prospective cohort study","volume":"116","author":"Aucott JN","year":"2022","unstructured":"Aucott JN, Yang T, Yoon I, Powell D, Geller SA, Rebman AW. Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: a prospective cohort study. Int J Infect Dis. 2022, 116:230-7. 10.1016\/j.ijid.2022.01.033","journal-title":"Int J Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/art.39866","article-title":"Autoimmune arthritides, rheumatoid arthritis, psoriatic arthritis, or peripheral spondyloarthritis following Lyme disease","volume":"69","author":"Arvikar SL","year":"2017","unstructured":"Arvikar SL, Crowley JT, Sulka KB, Steere AC. Autoimmune arthritides, rheumatoid arthritis, psoriatic arthritis, or peripheral spondyloarthritis following Lyme disease. Arthritis Rheumatol. 2017, 69:194-202. 10.1002\/art.39866","journal-title":"Arthritis Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-007-0342-0","article-title":"Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome","volume":"26","author":"Seidel MF","year":"2007","unstructured":"Seidel MF, Domene AB, Vetter H. Differential diagnoses of suspected Lyme borreliosis or post-Lyme-disease syndrome. Eur J Clin Microbiol Infect Dis. 2007, 26:611-7. 10.1007\/s10096-007-0342-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24646","article-title":"Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection","volume":"115","author":"Soulas P","year":"2005","unstructured":"Soulas P, Woods A, Jaulhac B, Knapp AM, Pasquali JL, Martin T, Korganow AS. Autoantigen, innate immunity, and T cells cooperate to break B cell tolerance during bacterial infection. J Clin Invest. 2005, 115:2257-67. 10.1172\/JCI24646","journal-title":"J Clin Invest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/qcupkk","article-title":"Autoantibodies in post-treatment Lyme disease and association with clinical symptoms","volume":"42","author":"Keshtkarjahromi M","year":"2024","unstructured":"Keshtkarjahromi M, Rebman AW, Antar AA, et al.. Autoantibodies in post-treatment Lyme disease and association with clinical symptoms. Clin Exp Rheumatol. 2024, 42:1487-90. 10.55563\/clinexprheumatol\/qcupkk","journal-title":"Clin Exp Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2017.00224","article-title":"The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment lyme disease syndrome","volume":"4","author":"Rebman AW","year":"2017","unstructured":"Rebman AW, Bechtold KT, Yang T, Mihm EA, Soloski MJ, Novak CB, Aucott JN. The clinical, symptom, and quality-of-life characterization of a well-defined group of patients with posttreatment lyme disease syndrome. Front Med (Lausanne). 2017, 4:224. 10.3389\/fmed.2017.00224","journal-title":"Front Med (Lausanne)"},{"key":"ref8","article-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2023","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria; 2023."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247384","article-title":"A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure","volume":"16","author":"Nilsson K","year":"2021","unstructured":"Nilsson K, Skoog E, Jones V, et al.. A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure. PLoS One. 2021, 16:e0247384. 10.1371\/journal.pone.0247384","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/32.7.546","article-title":"The relation between class-specific serum rheumatoid factors and age in the general population","volume":"32","author":"van Schaardenburg D","year":"1993","unstructured":"van Schaardenburg D, Lagaay AM, Otten HG, Breedveld FC. The relation between class-specific serum rheumatoid factors and age in the general population. Br J Rheumatol. 1993, 32:546-9. 10.1093\/rheumatology\/32.7.546","journal-title":"Br J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF02030749","article-title":"A study of IgM rheumatoid factors in a middle-aged population of Northern Norway","volume":"3","author":"Gran JT","year":"1984","unstructured":"Gran JT, Johannessen A, Husby G. A study of IgM rheumatoid factors in a middle-aged population of Northern Norway. Clin Rheumatol. 1984, 3:163-8. 10.1007\/BF02030749","journal-title":"Clin Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.55730\/1300-0144.5872","article-title":"Nationwide study on the prevalence of rheumatoid factor and anticitrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis","volume":"54","author":"Sati\u015f H","year":"2024","unstructured":"Sati\u015f H, Erden A, Bilgin E, et al.. Nationwide study on the prevalence of rheumatoid factor and anticitrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis. Turk J Med Sci. 2024, 54:949-55. 10.55730\/1300-0144.5872","journal-title":"Turk J Med Sci"},{"key":"ref13","article-title":"IgM rheumatoid factor in Lyme disease: correlation with disease activity, total serum IgM, and IgM antibody to Borrelia burgdorferi","volume":"14","author":"Kujala GA","year":"1987","unstructured":"Kujala GA, Steere AC, Davis JS 4th. IgM rheumatoid factor in Lyme disease: correlation with disease activity, total serum IgM, and IgM antibody to Borrelia burgdorferi. J Rheumatol. 1987, 14:772-6.","journal-title":"J Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.12.757","article-title":"Increased IgA rheumatoid factor and V(H)1 associated cross reactive idiotype expression in patients with Lyme arthritis and neuroborreliosis","volume":"58","author":"Axford JS","year":"1999","unstructured":"Axford JS, Rees DH, Mageed RA, Wordsworth P, Alavi A, Steere AC. Increased IgA rheumatoid factor and V(H)1 associated cross reactive idiotype expression in patients with Lyme arthritis and neuroborreliosis. Ann Rheum Dis. 1999, 58:757-61. 10.1136\/ard.58.12.757","journal-title":"Ann Rheum Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/art.39664","article-title":"Role of anti-carbamylated protein antibodies compared to anti-citrullinated protein antibodies in indigenous North Americans with rheumatoid arthritis, their first-degree relatives, and healthy controls","volume":"68","author":"Koppejan H","year":"2016","unstructured":"Koppejan H, Trouw LA, Sokolove J, et al.. Role of anti-carbamylated protein antibodies compared to anti-citrullinated protein antibodies in indigenous North Americans with rheumatoid arthritis, their first-degree relatives, and healthy controls. Arthritis Rheumatol. 2016, 68:2090-8. 10.1002\/art.39664","journal-title":"Arthritis Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180897","article-title":"Anticyclic citrullinated peptide antibodies 3.1 and anti-CCP-IgA are associated with increasing age in individuals without rheumatoid arthritis","volume":"46","author":"Berens HM","year":"2019","unstructured":"Berens HM, Polinski KJ, Mikuls TR, et al.. Anticyclic citrullinated peptide antibodies 3.1 and anti-CCP-IgA are associated with increasing age in individuals without rheumatoid arthritis. J Rheumatol. 2019, 46:1556-9. 10.3899\/jrheum.180897","journal-title":"J Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle MR","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003, 349:1526-33. 10.1056\/NEJMoa021933","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001732","article-title":"The value of musculoskeletal ultrasound for evaluation of postinfectious Lyme arthritis","volume":"28","author":"Miller JB","year":"2022","unstructured":"Miller JB, Albayda J, Aucott JN. The value of musculoskeletal ultrasound for evaluation of postinfectious Lyme arthritis. J Clin Rheumatol. 2022, 28:e605-8. 10.1097\/RHU.0000000000001732","journal-title":"J Clin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/357725-prevalence-of-rheumatoid-factor-and-anti-citrullinated-protein-antibodies-in-patients-with-post-treatment-lyme-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T23:01:51Z","timestamp":1745017311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/357725-prevalence-of-rheumatoid-factor-and-anti-citrullinated-protein-antibodies-in-patients-with-post-treatment-lyme-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.82541","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}